ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.

Chen, Pie-Che*; Yu, Chih-Chia*; Huang, Wen-Yu; Huang, Wan-Hong*; Chuang, Yu-Ming*; Lin, Ru-Inn*; Lin, Jora M J*; Lin, Hon-Yi*; Jou, Yeong-Chin*; Shen, Cheng-Huang*; Chan, Michael W Y*
Cancers (Basel)2019-9-28DOI: 10.3390/cancers11101457
9阅读
引用收藏
分享

摘要

MicroRNAs (miRNAs) have been shown to play a crucial role in the progression of human cancers, including urothelial carcinoma (UC), the sixth-most common cancer in the world. Among them, miR-34a has been implicated in the regulation of cancer stem cells (CSCs); however, its role in UC has yet to be fully elucidated. In this study, bioinformatics and experimental analysis confirmed that miR-34a targets CD44 (a CSC surface marker) and c-Myc (a well-known cell cycle regulator) in UC. We found that, surprisingly, most UC cell lines and patient samples did express miR-34a, although epigenetic silencing by promoter hypermethylation of miR-34a expression was observed only in UMUC3 cells, and a subset of patient samples. Importantly, overexpression of c-Myc, a frequently amplified oncogene in UC, was shown to upregulate CD44 expression through a competing endogenous RNA (ceRNA) mechanism, such that overexpression of the c-Myc 3'UTR upregulated CD44, and vice versa. Importantly, we observed a positive correlation between the expression of c-Myc and CD44 in clinical samples obtained from UC patients. Moreover, overexpression of a dominant-negative p53 mutant downregulated miR-34a, but upregulated c-Myc and CD44, in UC cell lines. Functionally, the ectopic expression of miR-34a was shown to significantly suppress CD44 expression, and subsequently, suppression of cell growth and invasion capability, while also reducing chemoresistance. In conclusion, it appears that aberrant promoter methylation, and c-Myc-mediated ceRNA mechanisms, may attenuate the function of miR-34a, in UC. The tumor suppressive role of miR-34a in controlling CSC phenotypes in UC deserves further investigation.

学科与关键词

关键词
CD44c-MycceRNAmiR-34aurothelial carcinoma
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancers (Basel)
发表日期
2019-09-28
卷期
第 11 卷, 第 10 期
DOI
10.3390/cancers11101457
成果收录
PUBMED

作者

  • C

    Chen, Pie-Che (通讯) (第一作者)

  • Y

    Yu, Chih-Chia (通讯)

查看全部 11 位作者收起作者
  • H

    Huang, Wen-Yu

  • H

    Huang, Wan-Hong (通讯)

  • C

    Chuang, Yu-Ming (通讯)

  • L

    Lin, Ru-Inn (通讯)

  • L

    Lin, Jora M J (通讯)

  • L

    Lin, Hon-Yi (通讯)

  • J

    Jou, Yeong-Chin (通讯)

  • S

    Shen, Cheng-Huang (通讯)

  • C

    Chan, Michael W Y (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417